The risk of cardiovascular events and all-cause mortality is increased in patients with CKD when there are elevated levels of cytokines such as TNF-α and IL-6 and when interleukin-1α (IL-1α) is expressed on the surface of circulating monocytes. The gene discussed is IL6; the disease is chronic kidney disease.